SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-055991
Filing Date
2021-04-28
Accepted
2021-04-28 07:33:29
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm212513d2_defa14a.htm DEFA14A 29197
2 GRAPHIC tm212513d2_defa14aimg01.jpg GRAPHIC 367011
  Complete submission text file 0001104659-21-055991.txt   535681
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38650 | Film No.: 21861357
SIC: 2834 Pharmaceutical Preparations